Aliki Taylor

2.5k total citations · 1 hit paper
50 papers, 1.7k citations indexed

About

Aliki Taylor is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Aliki Taylor has authored 50 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 21 papers in Pulmonary and Respiratory Medicine and 11 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Aliki Taylor's work include Lung Cancer Treatments and Mutations (16 papers), Acute Lymphoblastic Leukemia research (9 papers) and Colorectal Cancer Treatments and Studies (8 papers). Aliki Taylor is often cited by papers focused on Lung Cancer Treatments and Mutations (16 papers), Acute Lymphoblastic Leukemia research (9 papers) and Colorectal Cancer Treatments and Studies (8 papers). Aliki Taylor collaborates with scholars based in United Kingdom, United States and South Korea. Aliki Taylor's co-authors include Raoul C. Reulen, D. Winter, Emma Lancashire, Clare Frobisher, John Primrose, Fionna Mowat, Michael A. Choti, Graeme J. Poston, Wendy Langeberg and Gena Kanas and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Journal of Clinical Epidemiology.

In The Last Decade

Aliki Taylor

49 papers receiving 1.7k citations

Hit Papers

Survival after liver resection in metastatic colorectal c... 2012 2026 2016 2021 2012 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Survival after liver resection in metastatic colorectal cancer: review and meta-analysis of prognostic factors
    2012 488 citations Aliki Taylor et al. Clinical Epidemiology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aliki Taylor United Kingdom 18 613 434 359 340 322 50 1.7k
Margaret Kemeny United States 23 1.4k 2.2× 95 0.2× 295 0.8× 494 1.5× 364 1.1× 71 2.7k
Fadi Haddad United States 20 562 0.9× 123 0.3× 493 1.4× 262 0.8× 244 0.8× 190 1.7k
Wakiko Ajiki Japan 29 1.2k 2.0× 132 0.3× 277 0.8× 877 2.6× 728 2.3× 66 2.7k
Sheetal Kircher United States 22 972 1.6× 122 0.3× 251 0.7× 210 0.6× 199 0.6× 108 1.8k
M J Quinn United Kingdom 24 1.1k 1.9× 167 0.4× 229 0.6× 655 1.9× 498 1.5× 40 2.2k
Reda Wilson United States 20 985 1.6× 219 0.5× 265 0.7× 460 1.4× 258 0.8× 42 2.3k
Angela C. Tramontano United States 23 635 1.0× 88 0.2× 201 0.6× 562 1.7× 441 1.4× 74 1.6k
Hope E. Uronis United States 24 1.5k 2.4× 104 0.2× 167 0.5× 848 2.5× 628 2.0× 119 2.3k
Eva Segelov Australia 25 1.4k 2.4× 107 0.2× 205 0.6× 419 1.2× 417 1.3× 158 2.4k
Gabriel A. Brooks United States 19 919 1.5× 145 0.3× 390 1.1× 420 1.2× 598 1.9× 90 1.7k

Countries citing papers authored by Aliki Taylor

Since Specialization
Citations

This map shows the geographic impact of Aliki Taylor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aliki Taylor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aliki Taylor more than expected).

Fields of papers citing papers by Aliki Taylor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aliki Taylor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aliki Taylor. The network helps show where Aliki Taylor may publish in the future.

Co-authorship network of co-authors of Aliki Taylor

This figure shows the co-authorship network connecting the top 25 collaborators of Aliki Taylor. A scholar is included among the top collaborators of Aliki Taylor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aliki Taylor. Aliki Taylor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kalinsky, Kevin, Laura M. Spring, Clinton Yam, et al.. (2024). Real-world use patterns, effectiveness, and tolerability of sacituzumab govitecan for second-line and later-line treatment of metastatic triple-negative breast cancer in the United States. Breast Cancer Research and Treatment. 208(1). 203–214. 6 indexed citations
2.
Kalinsky, Kevin, Laura M. Spring, Clinton Yam, et al.. (2023). Real-world outcomes in patients (pts) with metastatic triple-negative breast cancer (mTNBC) treated with sacituzumab govitecan (SG) in 2L+ in the United States (US).. Journal of Clinical Oncology. 41(16_suppl). e18879–e18879. 2 indexed citations
3.
Subramanian, Janakiraman, Natasha B. Leighl, Yoon‐La Choi, et al.. (2022). Usage of epidermal growth factor mutation testing and impact on treatment patterns in non-small cell lung cancer: An international observational study. Lung Cancer. 175. 47–56. 1 indexed citations
4.
Nieva, Jorge J., Karen L. Reckamp, Danielle Potter, Aliki Taylor, & Ping Sun. (2022). Retrospective Analysis of Real-World Management of EGFR-Mutated Advanced NSCLC, After First-Line EGFR-TKI Treatment: US Treatment Patterns, Attrition, and Survival Data. Drugs - Real World Outcomes. 9(3). 333–345. 15 indexed citations
5.
Shah, Riyaz, Nicolas Girard, Saurabh Nagar, et al.. (2021). European and US Real-World Treatment Patterns in Patients with Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer: A Retrospective Medical Record Review. Drugs - Real World Outcomes. 8(4). 537–545. 9 indexed citations
6.
Wong, Janet Yuen Ha, Antoinette M. Lee, Dyt Fong, et al.. (2021). Lived experience of dietary change among Chinese colorectal cancer survivors in Hong Kong: A qualitative study. BMJ Open. 11(8). e051052–e051052. 6 indexed citations
7.
John, Thomas, et al.. (2021). Uncommon EGFR mutations in non-small-cell lung cancer: A systematic literature review of prevalence and clinical outcomes. Cancer Epidemiology. 76. 102080–102080. 44 indexed citations
8.
9.
Clifford, Sarah, Aliki Taylor, Michele Gerber, et al.. (2020). Concepts and Instruments for Patient-Reported Outcome Assessment in Celiac Disease: Literature Review and Experts’ Perspectives. Value in Health. 23(1). 104–113. 11 indexed citations
10.
Reckamp, Karen L., Jorge J. Nieva, Aliki Taylor, et al.. (2019). P1.01-105 US Real-World Management of EGFR-Mutated Advanced NSCLC: Prescribing and Attrition Data from First-To-Second-Line Treatment. Journal of Thoracic Oncology. 14(10). S402–S402. 4 indexed citations
11.
John, Thomas, et al.. (2019). P1.01-136 Uncommon EGFR Mutations in Non-Small Cell Lung Cancer: A Systematic Literature Review of Prevalence and Clinical Outcomes. Journal of Thoracic Oncology. 14(10). S416–S417. 1 indexed citations
12.
Mearns, Elizabeth S., Aliki Taylor, Talia Boulanger, et al.. (2019). Diagnosis and Treatment Patterns in Celiac Disease. Digestive Diseases and Sciences. 64(8). 2095–2106. 45 indexed citations
13.
Mearns, Elizabeth S., Aliki Taylor, Talia Boulanger, et al.. (2018). Systematic Literature Review of the Economic Burden of Celiac Disease. PharmacoEconomics. 37(1). 45–61. 30 indexed citations
14.
Zagadailov, Erin, et al.. (2016). Treatment Outcomes Of Relapsed/ Refractory Hodgkin’s Lymphoma Post-Asct: A Systematic Review. Value in Health. 19(3). A139–A139. 1 indexed citations
15.
Nielsson, Malene Schou, Rune Erichsen, Trine Frøslev, et al.. (2012). Positive predictive values of the coding for bisphosphonate therapy among cancer patients in the Danish National Patient Registry. Clinical Epidemiology. 4. 233–233. 6 indexed citations
16.
Taylor, Aliki, Adam P. Croft, D. Winter, et al.. (2009). Risk of thyroid cancer in survivors of childhood cancer: Results from the British Childhood Cancer Survivor Study. International Journal of Cancer. 125(10). 2400–2405. 81 indexed citations
17.
Taylor, Aliki, D. Winter, Kathy Pritchard‐Jones, et al.. (2008). Second primary neoplasms in survivors of Wilms' tumour—A population‐based cohort study from the British Childhood Cancer Survivor Study. International Journal of Cancer. 122(9). 2085–2093. 47 indexed citations
18.
Hawkins, Michael M., Emma Lancashire, D. Winter, et al.. (2007). The British Childhood Cancer Survivor Study: Objectives, methods, population structure, response rates and initial descriptive information. Pediatric Blood & Cancer. 50(5). 1018–1025. 179 indexed citations
19.
Taylor, Aliki, D. Winter, Charles Stiller, Mike Murphy, & Mike Hawkins. (2006). Risk of breast cancer in female survivors of childhood Hodgkin's disease in Britain: A population‐based study. International Journal of Cancer. 120(2). 384–391. 41 indexed citations
20.
Taylor, Aliki, Mike Hawkins, Helena Davies, et al.. (2004). Long‐term follow‐up of survivors of childhood cancer in the UK. Pediatric Blood & Cancer. 42(2). 161–168. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Margaret Kemeny Breakdown of academic impact, for papers by Fadi Haddad Breakdown of academic impact, for papers by Wakiko Ajiki Breakdown of academic impact, for papers by Sheetal Kircher Breakdown of academic impact, for papers by M J Quinn Breakdown of academic impact, for papers by Reda Wilson Breakdown of academic impact, for papers by Angela C. Tramontano Breakdown of academic impact, for papers by Hope E. Uronis Breakdown of academic impact, for papers by Eva Segelov Breakdown of academic impact, for papers by Gabriel A. Brooks
Rankless by CCL
2026